| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Koch Kevin serves as a President And CEO at EWTX. Across recent SEC filings that breaks down to 0 buys and 10 sells.
Historically, Koch Kevin's trades have earned a middling insider score of 55/100 across 7 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -26.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | President And CEO | Sale+OE | 17,971 | $43.68 | $785,042.06 | -25.5% | - | - | |
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | President And CEO | Sale+OE | 7,972 | $13.39 | $106,764.21 | -20.7% | +36.5% | - | |
| May 2, 2025 | EWTX Edgewise Therapeutics, Inc. | President And CEO | Sale+OE | 4,276 | $16.45 | $70,358.16 | -17.2% | -15.7% | +81.0% | |
| Mar 7, 2025 | EWTX Edgewise Therapeutics, Inc. | President And CEO | Sale+OE | 100 | $30.00 | $3,000.00 | -0.7% | -47.1% | -0.7% | |
| Feb 6, 2025 | EWTX Edgewise Therapeutics, Inc. | President And CEO | Sale+OE | 9,536 | $30.13 | $287,315.62 | -39.7% | -49.4% | +1.4% | |
| May 2, 2024 | EWTX Edgewise Therapeutics, Inc. | President And CEO | Sale+OE | 3,152 | $18.91 | $59,604.32 | -17.9% | -11.7% | -12.3% | |
| May 2, 2023 | EWTX Edgewise Therapeutics, Inc. | President And CEO | Sale+OE | 3,203 | $8.90 | $28,522.39 | -30.8% | -16.7% | +117.3% |